The U.S. Food and Drug Administration in 2010 issued a Plavix warning label to reflect that information. Bristol Myers and Sanofi faced a similar lawsuit from New Mexico, which settled in 2022.

Sanofi-Aventis may take the heavier hit in its partnership with Bristol-Myers Squibb as the anticoagulant Plavix goes generic in Europe. The Eurozone gave a green light to six Plavix generics last ...

Bristol-Myers Squibb Co. and Sanofi were ordered to pay the state of Hawaii more than $834 million for illegally marketing their blockbuster blood-thinning drug Plavix in a manner that put some users’ ...

Sanofi-Aventis and Bristol-Myers Squibb Co. said they had settled a dispute with generic drug maker Apotex Inc. that could keep patent protection on their multibillion-dollar blood thinner Plavix ...

BOSTON (MarketWatch) -- A federal court has ruled that a key patent held by Sanofi-Aventis on the blockbuster drug Plavix is valid -- a move that should stave off generic competition for the ...

Sanofi-Aventis, which developed Plavix, co-markets the drug with Bristol-Myers Squibb Co. The subpoenas were issued in connection with a Justice Department investigation of Bristol-Myers ...

Sanofi-Aventis, and the Medicines Company; and having provided expert testimony regarding clopidogrel (the compensation was donated to a nonprofit organization). Dr. Fox reports having received ...

PARIS, Jan 18 (Reuters) - The odds on Sanofi-Aventis saving its patent on blockbuster Plavix from generic rivalry in the United States have improved, freeing the French drugmaker's hand for ...

French drug maker Sanofi-Aventis SA warned that generic copies of the blood-thinner Plavix already on the market would undermine 2006 profit, as investors criticized Sanofi and partner Bristol ...

Bristol-Myers Squibb Co. and Sanofi were ordered to pay the state of Hawaii more than $834 million for illegally marketing their blockbuster blood-thinning drug Plavix in a manner that put some ...

Bristol-Myers Squibb Co. and Sanofi were ordered to pay the state of Hawaii more than $834 million for illegally marketing their blockbuster blood-thinning drug Plavix in a manner that put some ...